Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2018
Total Assets: $85.9M
Liabilities Breakdown FY2018
Total Liabilities: $25.7M
Asset Breakdown
Total Assets: $85.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $55.7M | 64.8% |
| Accounts Receivable | $1.7M | 1.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.3M | 3.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $25.3M | 29.5% |
Liabilities Breakdown
Total Liabilities: $25.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 5.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $24.2M | 94.1% |